losartan
losartan: sourced relationships with 1 company · 3 clinical trials tracked · 1 FDA decision.
losartan evidence translation
What we can confirm
1 FDA record · 3 tracked trials
What it means
What to watch
Prepared research question
How could losartan → TEVA affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| Teva Pharmaceutical Industries Limited (TEVA) Reported 2010-04-06 · Current development: unknownSource | Approved |
Clinical Trial Registry Records (3)
The Effects of Single-dose Losartan on the Processing of Emotional Information in Healthy Adolescents: a Randomised Controlled Study
Primary endpoint: Fear Extinction
A Phase II Study of FOLFIRINOX Combined With the Glycogen Synthase Kinase-3 Beta (GSK-3 β) Inhibitor Elraglusib and the Transforming Growth Factor-β (TGF-β) Inhibitor Losartan in Patients With Untreated Metastatic Pancreatic Adenocarcinoma
Primary endpoint: Progression-free survival (PFS)
SHAPER: A Phase 1 Study of Losartan and Hypofractionated Radiation Therapy After Induction Chemotherapy for Borderline Resectable or Locally Advanced Pancreatic Cancer
Primary endpoint: Rate of dose-limiting toxicities (DLTs)
Frequently asked questions
Which companies have sourced relationships with losartan?
losartan has dated SEC/FDA relationship records for Teva Pharmaceutical Industries Limited.
How many clinical trials involve losartan?
BioSniper tracks 3 clinical trials involving losartan.
What is losartan's latest FDA decision?
The most recent tracked FDA decision for losartan is Approval, dated April 6, 2010.